75 results
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
commercialization, marketing and manufacturing capabilities and strategy; risks related to the combined company’s ability to protect its intellectual … capabilities and strategy; risks related to the combined company’s ability to protect its intellectual property position; and the requirement for additional
6-K
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
to the combined company’s commercialization, marketing and manufacturing capabilities and strategy; risks related to the combined company’s ability to protect
6-K
EX-99.3
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
and strategy; risks related to the combined company’s ability to protect its intellectual property position; and the requirement for additional capital
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
;
regulatory authorities may require additional warnings on the label;
we may be required to create a Risk Evaluation and Mitigation Strategy, or REMS, plan … increase more than expected, our ability to generate and/or grow revenue could be reduced and we may not be able to implement our business strategy
F-3/A
nbt282u0hbijy3
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm
F-3
y3218 n3mv8
3 Nov 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.1
wyxs izlk9z
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.2
rwmqu85a4ki84levofc
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.1
ozpec8j d196
19 Sep 23
SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
6:16pm
6-K
b9qq3x2
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
424B5
3tspsg2nwm3
14 Aug 23
Prospectus supplement for primary offering
9:14am
424B3
ydlzx6gi7wyqtmb
10 Aug 23
Prospectus supplement
6:32am
6-K
EX-99.1
rhs553a8c 159uymqm
30 May 23
SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP
4:01pm
6-K
828583
30 May 23
SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP
4:01pm
424B5
rbhh35c kx9e
16 May 23
Prospectus supplement for primary offering
5:30pm
6-K
EX-99.1
vq8msk
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.2
dd2c2o89h 1y
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.1
0jgye
12 Aug 22
SciSparc Issued Israeli Patent for its Core Technology for Treating Central Nervous Systems Disorders
4:05pm